Literature DB >> 7876866

Treatment of paroxysmal symptoms in multiple sclerosis with bromocriptine.

O A Khan, M J Olek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7876866      PMCID： PMC1073332          DOI： 10.1136/jnnp.58.2.253

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  Paroxysmal attacks in multiple sclerosis.

Authors:  P O Ostermann; C E Westerberg
Journal:  Brain       Date:  1975-06       Impact factor: 13.501

2.  Immunodeficiency in hypophysectomized rats.

Authors:  E Nagy; I Berczi
Journal:  Acta Endocrinol (Copenh)       Date:  1978-11

3.  Treatment of paroxysmal symptoms in multiple sclerosis with ibuprofen.

Authors:  O A Khan
Journal:  Neurology       Date:  1994-03       Impact factor: 9.910

4.  Treatment with acetazolamide of brain-stem and spinal paroxysmal disturbances in multiple sclerosis.

Authors:  V Voiculescu; B Pruskauer-Apostol; C Alecu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-02       Impact factor: 10.154

5.  Immunomodulation by bromocriptine.

Authors:  E Nagy; I Berczi; G E Wren; S L Asa; K Kovacs
Journal:  Immunopharmacology       Date:  1983-10
  5 in total
  6 in total

Review 1.  Multiple sclerosis: symptomatic treatment.

Authors:  A J Thompson
Journal:  J Neurol       Date:  1996-08       Impact factor: 4.849

2.  Paroxysmal dysarthria and ataxia in multiple sclerosis and corresponding magnetic resonance imaging findings.

Authors:  Yongmei Li; Chun Zeng; Tianyou Luo
Journal:  J Neurol       Date:  2010-09-18       Impact factor: 4.849

3.  Harry Lee Parker and paroxysmal dysarthria and ataxia.

Authors:  James P Klaas; David B Burkholder; Wolfgang Singer; Christopher J Boes
Journal:  Neurology       Date:  2013-01-15       Impact factor: 9.910

4.  Pramipexole, a Dopamine D2/D3 Receptor-Preferring Agonist, Prevents Experimental Autoimmune Encephalomyelitis Development in Mice.

Authors:  Vicente Lieberknecht; Stella C Junqueira; Mauricio P Cunha; Thaís A Barbosa; Luiz F de Souza; Igor S Coelho; Adair R S Santos; Ana Lúcia S Rodrigues; Alcir L Dafré; Rafael C Dutra
Journal:  Mol Neurobiol       Date:  2016-01-22       Impact factor: 5.590

Review 5.  Targeting the Dopaminergic System in Autoimmunity.

Authors:  Pia M Vidal; Rodrigo Pacheco
Journal:  J Neuroimmune Pharmacol       Date:  2019-01-19       Impact factor: 4.147

6.  Dopaminergic stimulation leads B-cell infiltration into the central nervous system upon autoimmunity.

Authors:  Carolina Prado; Francisco Osorio-Barrios; Paulina Falcón; Alexandra Espinoza; Juan José Saez; María Isabel Yuseff; Rodrigo Pacheco
Journal:  J Neuroinflammation       Date:  2021-12-17       Impact factor: 8.322
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.